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Introduction: In former studies on ischaemic preconditioning,
adenosine was found to trigger this cardioprotective process.
After promising experiments in rabbit hearts and the first clini-
cal use during emergency percutaneous transluminal coronary
angioplasty in patients, we started to investigate the ability of
adenosine to protect the myocardium during standard cross-
clamping bypass surgery. Because adenosine is metabolized
within a few seconds, no systemic effects occur.
Method: Two groups of patients (placebo: n = 4, age
69.5 ± 5.2 years; adenosine: n = 4, 59.2 ± 10.3 years) were
studied. All patients of both groups were male, had an ejec-
tion fraction greater than 50%, and underwent three-vessel
bypass during elective cardiac surgery. On first aortic cross-
clamping, 5 mg/min adenosine was infused simultaneously
with a sufficient blood perfusion via the aortic root over
10 min. The patients in the placebo group received the same
dose of physiological saline solution. Blood samples were
collected before onset of anaesthesia, before the onset of
extracorporeal circulation (ECC), 1 h after the end of surgery,
and on the first and second days after surgery in order to
assess the following parameters: CK, CK-MB, LDH, GOT,
Table 1
Blood parameters and haemodynamic data
Parameters Placebo Adenosine Parameters Placebo Adenosine
CK (U/l) LVP (mmHg)
Before ECC 10 ± 8 6 ± 7 Before ECC Syst 100 ± 24 109 ± 12
1 h after surgery 252 ± 85 203 ± 63 Diast 7 ± 3 8 ± 2
1 day after surgery 314 ± 131 385 ± 138 End-diast 14 ± 5 14 ± 3
2 days after surgery 247 ± 161 189 ± 138 dP/dtmax 892 ± 145 850 ± 88
CK-MB (U/l) dP/dtmin –858 ± 191 –700 ± 96
Before ECC 1.0 ± 0.5 2 ± 3 After ECC Syst 109 ± 18 115 ± 20
1 h after surgery 26 ± 7 13 ± 8 Diast 5 ± 2 8 ± 5
1 day after surgery 26 ± 13 13 ± 19 End-diast 16 ± 3 23 ± 3
2 days after surgery 16 ± 17 5 ± 4 dP/dtmax 1345 ± 357 1039 ± 189
Troponin I (ng/ml) dP/dtmin –924 ± 174 –872 ± 58
Before ECC 0.5 ± 0.4 0.4 ± 0.1 ECC time (min) 117 ± 12 130 ± 18
1 h after surgery 56.0 ± 29.0 22.0 ± 6.0 Assisted ventilation (h) 9.0 ± 6.4 7.3 ± 6.6
1 day after surgery 97.0 ± 75.0 47.0 ± 40.0 Grafts 3.5 ± 0.5 3.5 ± 0.5
Available online http://ccforum.com/supplements/5/SBGPT, troponin I, potassium, sodium, Hb, Hct and leukocytes.
The following haemodynamic parameters were assessed: heart
rate, central venous pressure, left ventricular pressure (LVP),
and the maximal and minimal pressure rises (dP/dtmax and
dP/dtmin). For electrophysiological analyses, various ECG leads
were assessed.
Results: The blood parameters and haemodynamic data are
presented in Table 1. One placebo patient and two adenosine
patients needed mild intraoperative epinephrine treatment.
Whereas in the placebo group one patient developed first-
degree atrioventricular block, one patient receiving adenosine
showed absolute arrhythmia after surgery.
Conclusion: According to these preliminary results, there was
no significant difference between the two groups. This is prob-
ably explained by the small number of patients studied, or the
low temperature used during the ECC, which might have
obscured the expected beneficial effect of pharmacological
preconditioning.
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P2 Induction of myocardial heat shock protein-60 after cardioplegic arrest and reperfusion
A Schäfler, K Kirmanoglou, T Scheunert, P Pecher, A Hannekum and B Schumacher
Department of Cardiac Surgery, University of Ulm, Ulm, Germany
Introduction: Cardiomyocytes respond to stress with the
expression of various heat shock proteins (HSPs). Expression
of mitochondrial HSP60 is known to be induced by various
stress factors, including ischaemia and reperfusion. The aim of
the study was to investigate the induction of HSP60 in human
myocardium during cardiac surgery.
Method: From eight patients undergoing elective coronary
artery bypass grafting or valve replacement, samples of right
atrium were harvested before and after extracorporeal circula-
tion (ECC). Two patients had atrial fibrillation and six were in
sinus rhythm. The myocardial samples were excised and imme-
diately immersed in liquid nitrogen. The HSP60 protein level
was determined using sodium dodecyl sulphate–polyacryl-
amide gel electrophoresis, Western blot, and subsequent ECL
technique. The amount of HSP60 protein was quantified by
optical densitometry, according to the immunoreactive bands
of actin.
Results: In all samples HSP60 was detected before and after
ECC. We could not find any difference in HSP60 expression
before and during cardiac surgery. There was no correlation
with duration of cardiopulmonary bypass or reperfusion time.
Conclusion: We could not demonstrate a cytoprotective
upregulation of HSP60 after an obligatory period of ischaemia,
cardioplegic arrest and reperfusion. This might reflect effective
cardioprotection during ECC.
P3 Enhancement of neonatal myocardial function and cardiac energy metabolism following heat stress
pretreatment
S Vogt, D Troitzsch, H Abdul-Khaliq, PE Lange and R Moosdorf
Klinik für Herzchirurgie, Philipps-Universität Marburg/Lahn, Marburg/Lahn, Klinik für Angeborene Herzfehler-Kinderkardiologie,
Deutsches Herzzentrum Berlin, Berlin, Germany
Introduction: We investigated the capacity of heat stress to
improve myocardial tolerance and cardiac energy metabolism
in the isolated perfused neonatal rabbit heart subjected to pro-
longed cold cardioplegic ischemia.
Method: Hearts from anaesthetized male neonatal New
Zealand White rabbits (aged 8–10 days) were excised, iso-
lated, perfused with modified Krebs–Henseleit buffer, and
arrested for 2 h of cold cardioplegic ischaemia. In order to
induce the expression of heat shock proteins (HSPs;
HSP72+/73+) the rectal temperature of five neonatal rabbits
was raised to 42.0–42.5°C (in a whole-body water bath) for
15 min before the onset of global, hypothermic cardioplegic
arrest. Another set of five hearts without hyperthermia pretreat-
ment served as controls. The recovery of left ventricular (LV)
function was assessed by LV developed pressure, max +dP/dt
and LV pressure. The status of phosphorylated energy metabo-
lites (b-adenosine triphosphate [b-ATP], phosphocreatine
[PCr] and inorganic phosphate) was measured by 31phospho-
rus nuclear magnetic resonance spectroscopy. HSPs were
also detected by immunoblot analysis.
Results: Heat stress pretreatment resulted in significantly
better recovery of LV function, as indicated by LV developed
pressure (74.6 ± 10 versus 52.1 ± 8.5%: P < 0.05), max dP/dt
(910 ± 170 versus 530 ± 58 mmHg/s; P < 0.01), LV end-dias-
tolic pressure (8 ± 2 versus 18.4 ± 5 mmHg; P < 0.05) and
coronary blood flow (P < 0.05), than occurred in the control
group 60 min after reperfusion. During reperfusion, myocardial
energy metabolism was also better preserved in the HSP-
group hearts as a result of significantly (P < 0.05) increased
b-ATP and PCr values as compared with control animals.
Immunoblot analysis showed that the brief period of systemic
hyperthermia induced HSP (HSP 72+/73+) expression.c
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Conclusion: These data contribute to the evidence that heat
stress mediates a beneficial effect on recovery of the neonatal
left ventricle and cardiac energy metabolism after prolonged
cold cardioplegic ischaemia in rabbits.
P4 Transmembraneous dislocation of myocardial S100A1 calcium-binding protein during ischaemia and
reperfusion: a new marker of myocardial damage during cardiac surgery
Wolfgang Brett, Anna Mandinova*, Ueli Aebi* and Hans-Reinhard Zerkowski
Division of Cardio-Thoracic Surgery, University of Basel, Kantonsspital, and *ME Müller Institute, Biozentrum, University of Basel,
Basel, Switzerland
Introduction: Despite myocardial protection, ischaemia during
cardiopulmonary bypass induces greater or lesser degrees of
damage to cardiomyocytes as a result of transient cytosolic
calcium overload. Recently, increasing attention has been paid
to the role of heart-specific calcium-binding proteins in the
pathogenesis of myocardial ischaemia–reperfusion injury.
S100A1 is a heart-specific EF-hand calcium-binding protein,
which is directly involved in a variety of calcium-mediated
processes in human myocytes. 
Method: In order to elucidate the feasibility of using S100A1
calcium-binding protein for monitoring extended periods of
ischaemia, we attempted to characterize the ultrastructural
localization of S100A1 in the human heart under normal condi-
tions (baseline), after prolonged ischaemia and after reperfu-
sion. Confocal laser scanning microscopy was used to study
cardiac biopsies taken at these three time points, during car-
diopulmonary bypass in patients undergoing elective cardiac
surgery.
Results: Tissue samples obtained before initiation of extracor-
poreal circulation showed that S100A1 localized in the cyto-
plasm, which was strictly associated with actin contractile
filaments. Ischaemia of the heart (³30 min) induced specific
dislocation of S100A1 to the cell membrane and the interstitial
space. However, this dislocation was reversible after reperfu-
sion (³30 min).
Conclusion: These data suggest that S100A1 may be associ-
ated with transient perioperative myocardial damage despite
cardioplegia in the human heart. This protein, which is involved
in the regulation of contractile function of muscle cells, may be
an important intracellular marker for ischaemia–reperfusion
injury of the heart.
P5 Effects of high-dose methylprednisolone on neonatal pulmonary function after cardiopulmonary bypass and
deep hypothermic circulatory arrest
H Abdul-Khaliq, D Troitzsch, A Wehsack, S Schubert, W Böttcher, E Gutsch, M Hübler, R Hetzer and PE Lange
Klinik für Angeborene Herzfehler-Kinderkardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany
Introduction: Methylprednisolone has been widely used during
neonatal cardiac surgery with cardiopulmonary bypass (CPB),
in order to limit the inflammatory response and postperfusion
syndrome. However, the influence of high-dose methylpred-
nisolone pretreatment on postoperative respiratory function
and pulmonary haemodynamics in the neonate is controversial.
The aim of this investigation was to determine whether methyl-
prednisolone improves preperfusion and postperfusion pul-
monary function and haemodynamics.
Method: Sixteen newborn piglets (2.5 ± 0.5 kg body weight)
were subjected to CPB, and deep hypothermic circulatory
arrest (DHCA) was induced for 2 h. Group 1 (n = 8; control
group) did not receive any drug treatment and group 2 (n =8 )
received 30 mg/kg methylprednisolone preoperatively. Before
CPB and 20 min after bypass, blood samples and haemody-
namic data (cardiac output, mean arterial blood pressure, left
and right atrial pressure, pulmonary artery pressure [PAP])
were measured. Pulmonary oxygenation function was assessed
by calculating alveolar–arterial oxygen gradient index (AaI) and
respiratory index.
Results: Methylprednisolone pretreatment resulted in an
increase in prebypass values of PAP (14.0 ± 3.2 versus
10.3 ± 1.9 mmHg; P < 0.05), pulmonary vascular resistance
index (308 ± 81 versus 119 ± 44 dyns/cm5 per m2; P < 0.05),
AaI (279.8 ± 10 versus 174.5 ± 8.5 mmHg; P < 0.05) and
intrapulmonary shunt (10.12 ± 2.4 versus 4.6 ± 1.2%) as com-
pared with control animals, with no change in cardiac output,
stroke volume or systemic vascular resistance. All animals in
both groups had significantly (P < 0.05) and severely impaired
haemodynamics and lung function after CPB, including eleva-
tion of pulmonary vascular resistance with decreased pul-
monary oxygenation function and lower cardiac output, without
any intergroup differences.
Conclusion: Considering the significant increase in prebypass
pulmonary haemodynamic and oxygenation variables after high-
dose methylprednisolone pretreatment, these data do not
provide evidence that either postperfusion pulmonary haemo-
dynamics or oxygenation function are significantly influenced by
this treatment.
Available online http://ccforum.com/supplements/5/SBP6 Inhibition of cAMP phosphodiesterase by milrinone improves cardiac recovery after deep hypothermic
circulatory arrest
D Troitzsch, H Abdul-Khaliq, S Vogt, PE Lange and R Moosdorf
Klinik für Angeborene Herzfehler-Kinderkardiologie, Deutsches Herzzentrum Berlin, Berlin, and Klinik für Herzchirurgie, Philipps-
Universität Marburg/Lahn, Marburg/Lahn, Germany
Introduction: Perioperative cardiac dysfunction may be related
to inadequate myocardial protection during cardiopulmonary
bypass (CPB) and associated procedures. Many intrinsic and
extrinsic factors may act directly on vessels or indirectly by
release of vasoactive metabolites to alter vascular tone and
myocardial function during reperfusion. Milrinone, by inhibiting
cAMP-specific phosphodiesterase enzymes in both cardiac
and vascular smooth muscle, is a powerful inotrope and
vasodilator, but has little effect on systemic arterial blood pres-
sure. The purpose of the study was to investigate the effect of
milrinone administration on recovery of left ventricular (LV)
function and systemic haemodynamics after deep hypothermia
and CPB in rabbits.
Method: Fourteen New Zealand White rabbits (3.5 ± 0.5 kg
body weight) underwent CPB and deep hypothermic car-
diopulmonary arrest (DHCA) for 1 h. LV function and systemic
haemodynamics were compared between a control group
(n = 7) and a treatment group of animals (n = 7) that received a
loading dose of milrinone (50 mg/kg body weight) before the
onset of circulatory arrest, followed by slow release (0.5 mg/kg
pody weight per min) during reperfusion. LV and haemo-
dynamic measurements were taken before surgical interven-
tions and at 2 h after reperfusion.
Results: There were no statistical differences in baseline
values between the two groups. Perioperative treatment with
milrinone resulted in better recovery of LV function (max+dP/dt:
1206 ± 149 versus 1043 ± 134 mmHg/s [P < 0.05]; LV stroke
work index: 41 ± 2 versus 33 ± 2 gxm/m2 [P < 0.05]) and sig-
nificant changes in systemic haemodynamics (cardiac index:
3.1 ± 0.1 versus 2.2 ± 0.2 l/min per m2 [P < 0.05]; pulmonary
artery pressure: 13.2 ± 1.6 versus 18.6 ± 3.8 mmHg
[P < 0.05]; pulmonary vascular resistance: 550 ± 70 versus
1020 ± 110 dyns/cm5 per m2 [P < 0.01]), with no significant
change in mean arterial pressure, despite higher plasma cAMP
levels (19 ± 2 versus 12 ± 1.1 pmol/ml).
Conclusion: These data indicate that milrinone administration
acutely improves systemic haemodynamics and has beneficial
effects on recovery of myocardial function after deep hypother-
mic ischaemia. Milrinone and related drugs warrant further
investigation in the treatment of vascular tone and
ischaemia–reperfusion deterioration after CPB and DHCA.
P7 Effective value of myocardial tissue oxygen pressure monitoring during cold ischaemia and reperfusion
S Vogt, D Troitzsch, H Abdul-Khaliq, PE Lange and R Moosdorf
Klinik für Herzchirurgie, Philipps-Universität Marburg/Lahn, and Klinik für Angeborene Herzfehler-Kinderkardiologie, Deutsches
Herzzentrum Berlin, Berlin, Germany
Introduction: Recent studies have shown a relation between
altered myocardial function and the cardiac cellular changes
that are noted with hypothermic cardioplegic arrest, such as
energy store depletion and intracellular acidosis. The aim of the
study was to evaluate the link between myocardial energy
metabolism (high-energy phosphorylated compounds and intra-
cellular pH), as measured using 31phosphorus nuclear mag-
netic resonance spectroscopy (31P-MRS) and myocardial
tissue oxygen pressure (ptiO2) in isolated rabbit hearts sub-
jected to 2 h of cold cardioplegic ischaemia and reperfusion.
Method: Ten New Zealand White rabbits (male, 2.5 ± 0.5 kg
body weight) were anaesthetized with sodium pentobarbital
(45 mg/kg intravenous) and heparinized (700 IU/kg intra-
venous). The heart was rapidly excised, immersed in physiologi-
cal salt solution, cannulated and perfused in the Langendorff
mode at 37°C. After placing a minimally invasive, flexible
catheter partial oxygen tension microprobe (polarographic
Clark-type cell O2-sensor; Licox® system, GMS, Kiel, Germany)
into the left ventricular anterior wall, baseline data were
obtained after an equilibration period of 40 min. Hearts were
then subjected to 2 h at 10°C of cardioplegic ischaemia and
reperfused. The status of phosphorylated cardiac energy
metabolites (measured using a 4.7-T high-field 31P-MR spec-
trometer) was assessed, and myocardial tissue oximetry,
including temperature compensation, was measured using a
microsensor catheter probe (Licox®). Linear correlation was
performed between 31P-MRS data and ptiO2 readings.
Results: Intracellular pH (r = 0.58; P < 0.05), phosphocreatine
(r = 0.71;  P < 0.01) and inorganic phosphates (r = 0.62;
P < 0.05) measured after cardioplegic infusion and onset of
ischaemia correlated significantly with the decline in ptiO2.
During reperfusion, only intracellular pH (r = 0.76; P < 0.005)
and phosphocreatine (r = 0.84;  P < 0.005) values correlated
significantly with ptiO2.
Conclusion: On the basis of these findings, we conclude that
ptiO2 monitoring during surgically induced cold cardioplegic
ischaemia and reperfusion appears to provide a real-time mini-
mally invasive estimate of cardiac oxidative metabolism and cel-
lular energy consumption.
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P8 The effect of temperature during extracorporeal circulation on ultrastructure of cardiomyocytes
R Chakupurakal, B Hermanns*, JF Vazquez-Jiminez†, Ma Qing, S Lücking, BJ Messmer†, G von Bernuth and M-C Seghaye
Department of Pediatric Cardiology, *Institute of Pathology, and †Department of Cardiovascular Surgery, Aachen University of
Technology, Aachen, Germany
Introduction: Previous studies have suggested that mild
hypothermia (28°C) during extracorporeal circulation (ECC)
confers organ protection. The study was conducted to examine
whether temperature during ECC influences cardiomyocyte
ultrastructure.
Method: Fifteen pigs were randomly assigned to one of three
temperature groups (37, 28 and 20°C) during ECC (n =5
each). ECC time was 120 min and myocardial ischaemia time
was 60 min. Cardioplegia was achieved by injecting a crystal-
loid solution (4°C cold Bretschneider solution, 30 ml/kg) into
the aortic root. Flow index was set at 2.7 l/m2 per min. Six
hours after ECC, myocardial samples were taken from the left
ventricle for ultrastructural examination by electron microscopy.
Results: All animals showed intact contractile apparatus, with
normal texture of the myofibrils and normal configuration of the
Z-bands. Quantitative and structural changes of mitochondria
were frequent. Animals from the 37°C group showed marked
interstitial oedema and dehiscence of the cytoplasmatic mem-
brane with ruptures, whereas lesser damage to the membrane
was observed in the other two groups. The 28°C group
showed the least pronounced ultrastructural changes.
Conclusion: These results show that cardiac operations with
ECC are associated with ultrastructural lesions of the car-
diomyocytes. In this experimental setup, these lesions were
most pronounced under normothermic and least pronounced
under moderate hypothermic ECC.
P9 Heart failure impairs vasomotor functions of the mesenteric bed after cardiopulmonary bypass
G Szabó, TB Andrási*, E Zima*, P Soós*, F-U Sack, A Tanzeem, S Hagl and S Juhász-Nagy*
Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany, and *Department of Cardiovascular Surgery,
Semmelweis University, Budapest, Hungary
Introduction: Mesenteric dysfunction is a rare but severe com-
plication after open heart surgery, which may be aggravated by
coexistent heart failure. The aim of the study was to investigate
the effects of cardiopulmonary bypass (CPB) on intestinal vas-
cular endothelial and smooth muscle function in a canine model
of heart failure.
Method: Volume overload heart failure was induced by arterio-
venous shunt in six dogs; five healthy animals served as con-
trols. Heart rate, mean arterial pressure (MAP), mesenteric
blood flow and mesenteric vascular resistance (MVR) were
measured before and after 90 min of CPB. Reactive hyper-
aemic response and the response to acetylcholine and sodium
nitroprusside are expressed as percentage change in MVR. 
Results: Before CPB, baseline haemodynamics (MAP: 125 ± 5
versus 117 ± 10 mmHg; MVR: 0.96 ± 0.03 versus
0.99 ± 0.17 mmHg × min/ml), reactive hyperemia (–53 ± 5
versus –53 ± 2%), and response to acetylcholine (–41 ± 3
versus –55 ± 6%) and sodium nitroprusside (–68 ± 4 versus
–56 ± 4%) did not differ significantly. Ninety minutes after CPB,
there was a similar significant drop in MAP in both groups
(60 ± 17 and 51 ± 6 mmHg, respectively; P < 0.05 versus
baseline). After CPB, reactive hyperaemia (–16 ± 5 versus
–36 ± 15%;  P < 0.05) and response to acetylcholine (–22 ± 9
versus –42 ± 9%; P < 0.05) and to sodium nitroprusside
(–14 ± 4 versus –50 ± 7%; P < 0.002) exhibited a more pro-
nounced decrease in the heart failure than in the control group.
Conclusion: The development of heart failure per se does not
attenuate mesenteric vasomotor function. However, CPB
induces a more pronounced impairment of mesenteric
endothelium-dependent and -independent vasodilatory
response in animals with heart failure. This phenomenon may
have an impact on the higher incidence of mesenteric compli-
cations in cardiac patients with manifest heart failure.
P10 Noncardioplegic myocardial protection in high-risk coronary artery bypass grafting
G Kleikamp, N Reiß, N Mirow, B Hansky, A El-Banayosy, K Minami and R Körfer
Department of Thoracic and Cardiovascular Surgery, Heart Center NRW, Ruhr University of Bochum, Bad Oeynhausen,
Germany
Introduction: This study was undertaken to determine whether
intermittent aortic cross-clamping in the fibrillating heart can be
used successfully in high-risk coronary artery bypass grafting.
Method: From 1 January 1988 to 30 April 2000, 25,887
patients underwent isolated coronary bypass grafting for coro-
nary artery disease at our institution. In all cases, myocardial pro-
tection consisted of intermittent aortic cross-clamping in the fib-
rillating heart under mild hypothermia. A total of 908 patients
(797 male [88%]; mean age 60.1 ± 9.5 years, range 29–78
years) were suffering from ischaemic cardiomyopathy defined as
global (left ventricular ejection fraction <30%) and regional wall
motion abnormalties. The pre-, peri- and postoperative data for
this subgroup were entered prospectively into a database.Results: Mean aortic cross-clamp time was 25.01 ± 8.2 min
(range 0–46 min), mean perfusion time was 60.8 ± 26.3 min
(range 19–336 min), and the number of bypass grafts per
patient was 3.11 ± 0.927. Weaning from extracorporeal circu-
lation was possible without catecholamines in 348 patients
(38%); 560 (62%) received dopamine intravenously. Intra-
aortic balloon counterpulsation was used in 85 patients (9%)
and assist devices were used in nine patients. Twenty-eight
patients (3.1%) suffered from perioperative myocardial infarc-
tion, 96 patients developed ventricular arrhythmia and 191
atrial fibrillation. Ventilatory support for longer than 24 h was
required by 118 patients. Eighteen patients (2.0%) died within
30 days of the operation.
Conclusion: Intermittent aortic cross-clamping in the fibrillating
heart can be used safely for myocardial protection in all
patients undergoing surgical revascularization. The results even
in this high-risk group of patients compare favourably with all
published series utilizing other forms of myocardial protection.
Furthermore, this method is easy to use and cost neutral.
P11 Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
N Mirow, T Brinkmann, N Reiß, G Kleikamp, K Kleesiek and R Körfer
Herzzentrum NRW, Ruhr-Universiät Bochum, Bad Oeynhausen, Germany
Introduction: The aim of the study was to evaluate clinical and
coagulatory effects of low-molecular-weight heparin-coated
extracorporeal circulation (ECC) in coronary artery bypass
grafting (CABG). 
Method: CABG was performed in 287 patients, who were
included in a prospective, randomized study. In patients
treated using heparin coated technology (AOTHEL®; AOT,
Bad Oeynhausen, Germany), low-molecular-weight heparin
coating was employed. Conventional roller pumps and coro-
nary suction were used, and operations were performed in
conditions of moderate hypothermia, with application of inter-
mittent aortic cross-clamping. Patients were divided into three
groups. Group A (n = 97) had a standard uncoated ECC set
and intravenous heparin was administered at an initial dose of
400 IE/kg body weight; during ECC activated clotting time
(ACT) was kept at 480 s or greater. Group B (n = 94) had the
same ECC set but completely coated with low-molecular-
weight heparin, and intravenous heparin was administered at
the same dose as that employed in group A; ACT was kept at
the same level. Group C (n = 96) had the same coated ECC
set as group B, but intravenous heparin was reduced to
150 IE/kg, and during ECC ACT was set to be 240 s or
greater. Coagulatory effects were measured in a consecutive
subset of 119 patients.
Results: The coagulatory and clinical findings are presented in
Tables 1 and 2, respectively.
Table 1
Coagulatory findings during ECC
60 min ECC >60 and <120 min ECC
Group A  Group B  Group C  Group A  Group B  Group C 
Group (n = 39) (n = 42) (n = 38) (n = 39) (n = 42) (n = 38)
b-thromb (U/ml) 456.3 ± 210.6‡ 377.7 ± 338.7 298.9 ± 194.7* 425.3 ± 192.5 394.7 ± 158.6 348.8 ± 192.5
TAT (mg/l) 24.5 ± 19.0 25.1 ± 35.3 22.2 ± 14.9 28.3 ± 14.8‡ 34.6 ± 45.9 45.4 ± 34.3*
F1/2 (nmol/l) 2.5 ± 1.3 2.5 ± 1.6 2.7 ± 1.3 3.6 ± 2.7‡ 2.7 ± 1.6‡ 5.5 ± 4.2*†
D-dimers (mg/l) 0.3 ± 0.4 0.3 ± 0.3 0.3 ± 0.3 0.4 ± 0.5 0.4 ± 0.4 0.4 ± 0.3
*P < 0.05 versus group A; †P < 0.05 versus group B; and ‡P < 0.05 versus group C.
Table 2
Clinical findings
Group Neurologically Mechanically  Renal  Blood
deficient ventilation  insufficiency  loss  Hospital 
(n) (h) (n) (ml/12 h) Blood units/patient ICU stay (h) stay (days)
A (n = 97) 2 6.0 ± 5.2 0 453 ± 190 1.2 ± 1.6 22 ± 16 7.1 ± 1.5
B (n = 94) 1 5.2 ± 2.7 3 455 ± 190 1.1 ± 1.8 23 ± 16 7.3 ± 1.8
C (n = 96) 3 5.6 ± 2.9 2 361 ± 190* 0.7 ± 1.4† 25 ± 18 7.0 ± 1.5
ICU, intensive care unit. *P < 0.002 versus groups A and B; †P < 0.04 versus group A.
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Conclusion: CABG can be performed effectively employing
heparin-coated ECC. Thrombin generation is significantly ele-
vated by low intravenous heparinization at ECC durations greater
than 60 min, but fibrinolysis is not increased. Platelet activation is
less and there are few clinical complications, even if intravenous
heparin is greatly reduced. Significantly less postoperative bleed-
ing and need for blood replacement occurs only if coated ECC
technology is combined with low-dose systemic heparin.
P12 Implantation of HIA-Medos system in children with and without cardiopulmonary bypass
N Reiss, A El-Banayosy, T Breymann, G Kleikamp, N Mirow, K Minami and R Körfer
Clinic for Thoracic and Cardiovascular Surgery, Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Introduction: Mechanical circulatory assistance is a routine
procedure in severe heart failure. The goal of the HIA-Medos
system is to develop two miniaturized ventricles for cardiovas-
cular support in children. We report our experiences with
implantation of the HIA-Medos system in children with and
without cardiopulmonary bypass.
Method: A HIA-Medos system was implanted by cannulation in
the right atrium and the pulmonary artery for right heart support.
In bridge-to-transplant patients, the left ventricle and the
ascending aorta were cannulated for left heart support. In
those patients who were expected to recover, the left atrium
was cannulated. Cardiopulmonary bypass was instituted using
standard techniques.
Results: Five patients (ages 5 days, 5 months, and 1, 5 and
8 years) were supported. Body weights ranged from 3.5 to
20 kg, and body surface area from 0.19 to 0.83 m2. The under-
lying disease was myocarditis in two patients, dilatative car-
diomyopathy in one patient, d-transposition of the great arteries
in one patient, and undetected Bland–White–Garland syn-
drome in one patient. Four patients underwent biventricular
support, and one had left heart support. One patient had post-
operative low-output syndrome, who could be weaned after a
support time of 5 days. The HIA-Medos system was implanted
in three out of the four bridge-to-transplant patients, with car-
diopulmonary bypass. In these three patients re-exploration
was necessary because of bleeding complications due to dis-
turbed coagulation cascade. They received a mean of 2.9 ery-
throcyte concentrates per support day. The patients died
because of multiple organ failure, among other complications.
In the fourth child the HIA-Medos system was implanted
without cardiopulmonary bypass. No bleeding complication
occurred. Pre-existant organ dysfunction recovered. Distur-
bances of coagulation system were not apparent.
Conclusion: Postoperative bleeding is the most frequent com-
plication in children supported by the HIA-Medos system with
cardiopulmonary bypass. Multiple transfusions were necessary,
and the patients treated died because of multiple organ failure.
Implantation without cardiopulmonary bypass appears to
prevent bleeding complications, with nearly normal coagulation
conditions. Recovery of all pre-existent major organ dysfunc-
tions occurred.
P13 The clinical relevance of an elevated lactate level after surgery for congenital heart disease
C Bernhardt, C Weiss, J Breuer, M Kumpf and L Sieverding
Department of Pediatric Cardiology, University of Tübingen, Tübingen, Germany
Introduction: Lactate is a product of anaerobic glycolysis, and
may be increased due to inadequate oxygen supply, excessive
oxygen demand, liver failure or exogenous supply with blood
products. Children after cardiothoracic operations may therefore
be at risk for elevated lactate concentrations. We examined the
impact of elevated lactate levels on postoperative outcome.
Method: The records of 253 children, aged 1 day to 17 years,
who underwent open or closed cardiac surgery in our institution
between March 1997 and May 1998, were examined retrospec-
tively. Twenty children were excluded because of incomplete
data sets. The postoperative concentration of lactate was mea-
sured at the time of admission to our intensive care unit and was
related to intraoperative and postoperative data.
Results: Lactate concentrations for various durations of cardio-
pulmonary bypass (CPB) are shown in Table 1. The mean
lactate was 3.37 mmol/l on postoperative admission. In the 215
patients who survived, mean lactate was 2.8 (0.6–19.6) mmol/l,
versus 10.6 (2.1–22.4) mmol/l in the 18 children who died
during the postoperative period. In 10 children with multiple
organ failure lactate was 9.8 (2.1–19.6) mmol/l, versus 3.1
(0.6–22.4) mmol/l in children without. In 23 children who suf-
fered from neurological complications we found higher lactate
(9.0 [1.0–22.4] mmol/l) than in 210 children without (2.8
[0.6–21.3] mmol/l). In the group of children with a lactate level
Table 1
Lactate concentrations
Duration of CPB in minutes (n)
0 1–60  61–120  121–180  >181 
(37) (21) (91) (67) (17)
Lactate (mmol/l) 1.3 1.8 2.64 4.6 9.14
Available online http://ccforum.com/supplements/5/SBgreater than 6 mmol/l (n = 34) mortality was 41.1%, incidence
of multiple organ failure was 14.7% and incidence of neurologi-
cal complications was 44.1%. In contrast, in the group with
lactate levels below 6 mmol/l (n = 199) mortality rate was
2.0%, incidence of multiple organ failure was 5% and inci-
dence of neurological complications was 4.5%.
Conclusion: The concentration of lactate in the blood is higher
after operations with CPB then after those without, and the level
of lactate increases with the duration of CPB. The risk for post-
operative morbidity and mortality is increased with higher lactate
concentrations. Therefore, lactate concentration might be a valu-
able parameter during CPB and during the postoperative period.
P14 Phosphorylcholine-coated cardiopulmonary bypass in paediatric cardiac surgery improves biocompatibility:
reduced contact activation and endothelin-1 release
F Harig, R Cesnjevar, Y Lindemann, L Bumiller, H Singer* and M Weyand
Center of Cardiac Surgery and *Department of Pediatric Cardiology, Friedrich-Alexander University Erlangen-Nuerenberg,
Erlangen, Germany
Introduction: Modification of cardiopulmonary bypass (CPB)
circuits by using a phospholipid coating is a promising option
for improving biocompatibility of CPB and thus reducing CPB-
associated organ dysfunction. Endothelin-1 is a potent vaso-
constrictor peptide that is synthesized and secreted by
vascular endothelial cells. Its biological functions are wide-
spread, acting as a mitogen and stimulant of collagen synthe-
sis. It has been reported to be positively inotropic, to increase
after vascular injury, and to induce pulmonary vasoconstriction,
cardiac hypertrophy and heart failure. The aim of this study was
to analyze the impact of a new phospholipid coating with
respect to contact activation and endothelin-1 release in paedi-
atric cardiac surgery patients.
Method: We randomly assigned 20 neonates and young chil-
dren to two groups, using a completely phospholipid-coated
CPB circuit in group A (n = 10) and an equivalent but
uncoated set in group B (n = 10). The children were scheduled
for elective congenital heart surgery. Their parents gave
informed consent, and the study was approved by the local
ethics committee. Arterial blood samples were drawn at times
0, 30 min and 48 h, and analyzed using enzyme-linked
immunosorbent assay. The intensive care unit (ICU) course and
further recovery was studied with regard to the alveolar–arterial
oxygen gradient, the respiratory index, and duration of intuba-
tion and ICU stay.
Results: In group A mean age was 11.3 ± 4 days (range 6–24
days), with a mean body weight of 3.8 ± 0.2 kg (range
3.5–4.0 kg). In group B mean age was 172 ± 148 days (range
7–528 days, median 154 days), with a mean body weight of
4.8 ± 1.1 kg (range 3.0–5.9 kg). The average perfusion time in
group A was 125.8 ± 25.6 min, and in group B it was
78.5 ± 33.8 min; the mean cross-clamp time in group A was
44.3 ± 17.9 min, and in group in B it was 31 ± 16.8 min. In
both groups a significant loss of complement factors was
observed: in group A C3c 0.45 mg/ml versus 0.71 mg/ml, C4
0.08 versus 0.14 mg/ml; and in group B C3c 0.28 mg/ml
versus 0.68 mg/ml, C4 0.05 versus 0.13 mg/ml. The difference
between the groups (0.45 versus 0.28, and 0.08 versus 0.05)
is significant for C3, but not for C4. In both groups, comple-
ment factors normalized after 48 h. Endothelin-1 release was
significantly reduced in the phospholipid group, whereas in
group B elevated levels could be observed even after 48 h. The
respiration parameters, such as alveolar–arterial oxygen gradi-
ent and respiratory index, revealed advantages for group A
(240 ± 101 versus 375 ± 105, and 0.70 versus 1.60, respec-
tively). Parameters such as duration of intubation and ICU stay
should be considered with caution, because of the interindivid-
ual range of postoperative courses.
Conclusion: Phospholipid-coating of CPB circuit elements in
paediatric cardiac surgery leads to a lower C3 consumption,
which can also be observed with regard to C4. Improvement in
biocompatibilty is evident by reduced endothelin-1 release,
which may lead to decreased vasoconstriction and thus to a
decrease in cardiac afterload in postischaemic myocardium.
The reduction in oxygen consumption is likely to improve
clinical outcome. Clinical parameters such as respiration and
duration of ICU stay indicate beneficial effects for phospho-
lipid-treated patients; this needs confirmation in further studies
including many more patients, as have already been initiated.
P15 High oxygen treatment during preparation of children for open-heart surgery leads to a decrease in total
antioxidant capacity
CTA Evelo, SLM Coort, NJG Jansen*, JF Vazquez-Jimenez† and M-C Seghaye‡
Department of Pharmacology and Toxicology, Universiteit Maastricht, Maastricht, The Netherlands, *Pediatric ICU, Wilhelmina
Children’s Hospital, Utrecht, The Netherlands, and †Cardiac Surgery and ‡Pediatric Cardiology, Aachen University of Technology,
Aachen, Germany
Introduction: Children who undergo cardiac surgery with car-
diopulmonary bypass (CPB) often suffer myocardial damage
after the operation. It has been hypothesized that this damage
is enhanced by mechanisms that involve increased oxidative
stress. This oxidative stress damage could be caused by
ischaemia–reperfusion injury, which could be intensified by the
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high oxygen treatment that is used during CPB and by inflam-
matory activity. To verify this, we assessed the antioxidant
capacity in plasma samples collected at a number of time
points before, during and after CPB, from children undergoing
open-heart surgery.
Method: Total trolox equivalents in antioxidant capacity (TEAC)
were calculated from the reactivity toward the artificially gener-
ated 2,2¢-azinobis-(3-ethyl-benzothiazoline-6-sulfonic acid)
(ABTS) radical. To exclude the possibility that TEAC values
decrease as a result of haemodilution, we measured the triglyc-
eride content using the GPO-trinder (Sigma) reagent in a
microtitre-plate spectrophotometric analysis.
Results: Total antioxidant capacity was decreased shortly after
the onset of surgery in plasma of children (aged 8–14 months)
treated for ventricular septal defect (VSD; n = 17) and tetralogy
of Fallot (TOF; n = 15). Figure 1 shows a significant (Friedman
test; P < 0.05) decrease in both VSD and TOF from time point
1.1 (induction of anaesthesia) to time point 2 (heparin adminis-
tration before CPB). Decrease in TEAC values can therefore
not be a result of haemodilution during CPB. This was con-
firmed by the fact that total plasma triglyceride values did not
decrease between these time points. Shortly after CPB (time
point 4) the TEAC values were already significantly (P < 0.05)
higher than at time point 3 (10 min after the onset of CPB), and
they returned to normal during the 4 h after the operation and
remained normal thereafter.
Conclusion: We showed a decrease in antioxidant capacity
early during the operation, which could not have been caused
by haemodilution. The most likely cause appears to be the high
oxygen that was given during preparation for CPB. The
methodology described here will be useful for study of the influ-
ences of different approaches in, for example, oxygen treat-
ment, clamping techniques, temperature treatment and
antioxidant supply on the oxidative stress that occurs during
open-heart surgery.
Figure 1
Average TEAC and triglyceride values in infants with VSD or TOF.
Shown are changes in TEAC and triglyceride values before, during
(grey area) and after CPB.
P16 Myocardial cell damage related to arterial switch operation in neonates with transposition of the great arteries
HH Hövels-Gürich, JF Vazquez-Jimenez*, A Silvestri, K Schumacher, S Kreitz, J Duchateau†, BJ Messmer*, G von Bernuth
and M-C Seghaye*
Departments of Paediatric Cardiology and *Thoracic and Cardiovascular Surgery, Aachen University of Technology, Aachen,
Germany, and †Department of Immunology, Hôpital Brugman, Brussels, Belgium
Introduction: It was of objective of this study to investigate
clinical and laboratory risk factors for myocardial dysfunction
(MD) in neonates after arterial switch operation for transposi-
tion of the great arteries.
Method: Sixty-three neonates (age 2–28 [8.1 ± 4.6] days),
who were operated on under combined deep hypothermic
(15°C) circulatory arrest and low-flow cardiopulmonary bypass
(CPB), were studied. Inclusion criteria were transposition of the
great arteries with or without ventricular septal defect (VSD)
that was suitable for arterial switch operation (VSD–; n = 53),
and if necessary additional VSD closure (VSD+;  n = 10).
Patients were differentiated clinically into two groups by pres-
ence or absence of MD within 24 h after surgery. MD was
defined as myocardial ischaemia after coronary reperfusion
and/or myocardial hypocontractility as assessed by echocar-
diography. MD was related to clinical outcome parameters and
to perioperative release of cardiac troponin-T (cTnT) and pro-
duction of interleukin-6 and interleukin-8.
Results: MD was observed in 11 patients (17.5%). Two
patients died early after surgery from myocardial infarction, and
two died late after surgery (6.3%). CPB and cross-clamping,
but not deep hypothermic circulatory arrest times, were corre-
lated with MD; MD was more frequent in the VSD+ than in the
VSD– group because of longer support times. Coronary status
and age at surgery were not related to MD. Patients with MD
had more frequently impaired cardiac, respiratory and renal
functions. cTnT, interleukin-6 and interleukin-8 were signifi-
cantly elevated at the end of CPB, and 4 and 24 h after
surgery, as compared with preoperative values in both groups.
Postoperative cTnT, interleukin-6 and interleukin-8 concentra-
tions were significantly higher in MD patients than in the others.
Multivariable analysis of independent risk factors for MD
Available online http://ccforum.com/supplements/5/SBrevealed interleukin-6 4 h after surgery to be significant
(P = 0.04; odds ratio 1.24 [95% confidence interval
1.01–1.52] per 10 pg/ml). The cutoff point for prediction of MD
was set at 500 pg/ml (specificity 95.4%, sensitivity 72.7%).
Conclusion: Cardiac operations in neonates induce the pro-
duction of the proinflammatory cytokines interelukin-6 and inter-
leukin-8, as well as release of cTnT. These results suggest that
proinflammatory cytokines are, at least in part, responsible for
myocardial cell damage and MD occurring after arterial switch
operations in this age group.
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